/Companies

Piraeus Medical

Maple Grove, US · Founded 2021 · Delaware corporation

Find your way into Piraeus Medical

Sign up to see every warm intro you have to Piraeus Medical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Piraeus Medical team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Piraeus Medical develops catheters built with a patented linerless construction, including the NeuGlide+ (0.087" inner diameter, compatible with a 7F introducer sheath) and NeuFlex (0.093" inner diameter, compatible with an 8F introducer sheath). It operates in the medical device sector.

Founders & leadership

JHJared Hutar
Jared HutarExecutive
KK
Keith KallmesNamed on SEC filing
KK
Kevin KallmesNamed on SEC filing

Board

RE
Ryan EgelandBoard director
MO
Martin Omid AkhavanBoard director

Reported raises · per SEC filings

Form D private placements

$21.1M disclosed across 10 rounds · 2022–2026

▶$10.5MraisedOct 2026 · 25 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jared HutarExecutive Officer, Director
  • Kevin KallmesDirector
  • Keith KallmesDirector
  • Martin Omid AkhavanDirector
  • Ryan EgelandDirector
Offering amount
$12M
Amount sold
$10.5M
Minimum investment
$1K
First sale
Mar 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$662.6KraisedNov 2025 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ryan EgelandDirector
  • Keith KallmesDirector
  • Martin AkhavanDirector
  • Kevin KallmesDirector
  • Jared HutarExecutive Officer, Director
Offering amount
$2.2M
Amount sold
$662.6K
Minimum investment
$1K
First sale
Oct 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedSep 2025 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ryan EgelandDirector
  • Jared HutarExecutive Officer, Director
  • Keith KallmesDirector
  • Kevin KallmesDirector
  • Martin Omid AkhavanDirector
Offering amount
$300K
Amount sold
$300K
Minimum investment
$1
First sale
Sep 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedFeb 2025 · 65 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jared HutarExecutive Officer, Director
  • Martin Omid AkhavanDirector
  • Ryan EgelandDirector
  • Keith KallmesDirector
  • Kevin KallmesDirector
Offering amount
$2M
Amount sold
$2M
Minimum investment
$500
First sale
Feb 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedJul 2024 · 79 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jared HutarExecutive Officer, Director
  • Keith KallmesDirector
  • Kevin KallmesDirector
  • Ryan EgelandDirector
  • Martin Omid AkhavanDirector
Offering amount
$6M
Amount sold
$6M
Minimum investment
$25K
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$450KraisedApr 2024 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jared HutarExecutive Officer
  • Kevin KallmesDirector
  • Keith KallmesDirector
Offering amount
$3.5M
Amount sold
$450K
Minimum investment
$5K
Proceeds to insiders
$150K
First sale
Jun 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1KraisedAug 2023 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin KallmesDirector
  • Keith KallmesDirector
  • Jared HutarExecutive Officer
Offering amount
$3.1K
Amount sold
$3.1K
Minimum investment
$1
First sale
Aug 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150KraisedDec 2022 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith KallmesExecutive Officer, Director
  • Jared HutarExecutive Officer
  • Keith KallmesExecutive Officer, Director
Offering amount
$3.5M
Amount sold
$150K
Minimum investment
$1K
Proceeds to insiders
$200K
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

Companies working in the same space as Piraeus Medical.

Frequently asked questions

What does Piraeus Medical do?
Piraeus Medical develops catheters built with a patented linerless construction, including the NeuGlide+ (0.087" inner diameter, compatible with a 7F introducer sheath) and NeuFlex (0.093" inner diameter, compatible with an 8F introducer sheath). It operates in the medical device sector.
How much funding has Piraeus Medical raised?
Piraeus Medical has disclosed $21.1M raised across 10 rounds.
Where is Piraeus Medical headquartered?
Piraeus Medical is headquartered in Maple Grove, US.